Neuroprotection by chotosan, a Kampo formula, against glutamate excitotoxicity involves the inhibition of GluN2B-, but not GluN2A-containing NMDA receptor-mediated responses in primary cultured cortical neurons
Chotosan (CTS), a traditional herbal formula called Kampo medicine, was shown to be effective in the treatment of vascular dementia in a clinical study, and exerted protective effects against transient cerebral ischemia-induced cognitive impairment in mice. In the present study, we investigated the...
Saved in:
Main Authors: | Sachie Sasaki-Hamada (Author), Azusa Suzuki (Author), Emi Sanai (Author), Kinzo Matsumoto (Author), Jun-Ichiro Oka (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of a Subtype-Selective Allosteric Inhibitor of GluN1/GluN3 NMDA Receptors
by: Yue Zeng, et al.
Published: (2022) -
GluN2B but Not GluN2A for Basal Dendritic Growth of Cortical Pyramidal Neurons
by: Steffen Gonda, et al.
Published: (2020) -
The role of GluN2A and GluN2B NMDA receptor subunits in AgRP and POMC neurons on body weight and glucose homeostasis
by: Aykut Üner, et al.
Published: (2015) -
GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases
by: Amany Digal Ladagu, et al.
Published: (2023) -
Role of NMDA receptor GluN2D subunit in the antidepressant effects of enantiomers of ketamine
by: Soichiro Ide, et al.
Published: (2017)